Rafferty Asset Management
EWTX icon

Rafferty Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Rafferty Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245K Buy
+6,035
New +$208K ﹤0.01% 1054
2026
Q1 		– Sell
-9,849
Closed -$244K – 1091
2025
Q4 		$244K Buy
+9,849
New +$198K ﹤0.01% 1036
2025
Q2 		– Sell
-12,217
Closed -$269K – 1086
2025
Q1 		$269K Buy
12,217
+311
+3% +$8.16K ﹤0.01% 983
2024
Q4 		$318K Sell
11,906
-1,338
-10% -$42.6K ﹤0.01% 1018
2024
Q3 		$353K Buy
+13,244
New +$263K ﹤0.01% 1009

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rafferty Asset Management's EWTX Position: Q2 2026 in Review

Rafferty Asset Management opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 6,035 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #1054 among its holdings. This is a return to the name: Rafferty Asset Management previously reported a position in EWTX as recently as Q4 2025.

Rafferty Asset Management first reported a position in EWTX in Q3 2024 and has held it in 5 quarters since. The position peaked at $353K in Q3 2024. 227 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Rafferty Asset Management held 6,035 shares of Edgewise Therapeutics worth $245K as of Q2 2026.
  • Edgewise Therapeutics was a new Rafferty Asset Management position in Q2 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #1054 holding.
  • Rafferty Asset Management first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • Rafferty Asset Management's Edgewise Therapeutics position peaked at $353K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.